Literature DB >> 12876358

Crystallization and preliminary crystallographic analysis of the autoinhibited form of the tandem SH3 domain of p47(phox).

Satoru Yuzawa1, Nobuo N Suzuki, Yuko Fujioka, Kenji Ogura, Hideki Sumimoto, Fuyuhiko Inagaki.   

Abstract

p47(phox) is a cytosolic component of the phagocyte NADPH oxidase, which is responsible for the production of the superoxide which kills invasive microorgamisms. A recombinant form of a histidine-tagged tandem SH3 domain of the p47(phox)-containing polybasic autoinhibited region was expressed in Escherichia coli and purified and crystallized by the sitting-drop vapour-diffusion method at 293 K using polyethylene glycol 6000 as a precipitant. Diffraction data were collected to 2.15 A resolution at 100 K using synchrotron radiation. The crystal belongs to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = 100.02, c = 44.94 A. The presence of one molecule per asymmetric unit gives a crystal volume per protein mass (V(M)) of 2.6 A(3) Da(-1) and a solvent content of 52% by volume.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876358     DOI: 10.1107/s0907444903011636

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  2 in total

1.  Sequence-specific resonance assignments of the tandem SH3 domains in an autoinhibitory form of p47(phox).

Authors:  Satoru Yuzawa; Masashi Yokochi; Yuko Fujioka; Kenji Ogura; Hideki Sumimoto; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

2.  Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.

Authors:  Jean-Baptiste Garsi; Balázs Komjáti; Gregorio Cullia; Imre Fejes; Melinda Sipos; Zoltán Sipos; Eszter Fördős; Piroska Markacz; Barbara Balázs; Nathalie Lancelot; Sylvie Berger; Eric Raimbaud; David Brown; Laurent-Michel Vuillard; Laure Haberkorn; Cyprian Cukier; Zoltán Szlávik; Stephen Hanessian
Journal:  ACS Med Chem Lett       Date:  2022-05-10       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.